Kardemir Karabuk Demir Celik Sanayi ve Ticaret A Ord Shs. (844) 978-6257. Glassdoor has salaries, wages, tips, bonuses, and hourly pay based upon employee reports and estimates. General +1 (858) 333-7830 info@singulargenomics.com. **Green highlights the top performing ETF by % change in the past 100 days. Any such forward-looking statements are based on our managements current expectations and are subject to risks and uncertainties that could cause our actual future results to differ materially from our managements current expectations or those implied by our forward-looking statements. The estimated additional pay is $40,980 per year. Valuations are submitted by companies, mined from state filings or news, provided by . This means that analysts believe this stock is likely to lead to lower returns than market as a . ET by Tomi Kilgore. Continue. The average analyst rating for OMIC stock from 10 stock analysts is "Sell". Volume today is light. The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating. Singular Genomics Systems Inc 52 week high is $5.21 as of April 18, 2023. Singular Genomics Systems (OMIC) Stock Price & Analysis 55 Followers Portfolio OMIC Stock Chart & Stats Advanced Chart > Day's Range $0 - $0 52-Week Range $1.19 - $6.95 Previous Close $1.42 Volume 145.13K Average Volume (3M) 132.09K Market Cap $102.16M Enterprise Value -$83.58M Total Cash (Recent Filing) $244.58M Total Debt (Recent Filing) $58.84M It now looks like their preparing for an IPO and have filed an S-1. Singular Genomics's latest post-money valuation is from May 2021. What is Singular Genomics Systems Inc's EBITDA? 2022 was a pivotal year for Singular Genomics. Singular Genomic Systems S-1 Review. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as . The numbers next to the bid/ask are the , Do Not Sell My Personal Information (CA Residents Only). Not an offer or recommendation by Stocktwits. In 2023, we will remain focused on customer success across a growing installed base, commercial and operational execution, and advancing our innovation pipeline.. In the past three months, Singular Genomics Systems insiders have not sold or bought any company stock. Research & Science Based on 39 salaries Scientist II 5 salaries Scientist 5 salaries View More Engineering Based on 11 salaries QC Associate II 2 salaries Sr Engineer In development, the PX system leverages Singulars proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. 10 stocks we like better than Singular Genomics Systems, Inc. The average price target is $2.25 with a high forecast of $2.25 and a low forecast of $2.25. Singular Genomics Systems Incs P/E ratio is -0.85. Follow Us. August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com. The data displayed in the quote bar updates every 3 seconds; allowing you to monitor prices in real-time. The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023. formId: "6d6c14f2-ba94-427d-bb5a-a595d4237b34", All rights reserved. 21,081 followers. Lorsque vous utilisez nos sites et applications, nous utilisons des, authentifier les utilisateurs, appliquer des mesures de scurit, empcher les spams et les abus; et. Compare Top Brokerages Here. Pour en savoir plus sur la faon dont nous utilisons vos donnes personnelles, veuillez consulter notre politique relative la vie prive et notre politique en matire de cookies. According to analysts' consensus price target of $3.50, Singular Genomics Systems has a forecasted upside of 224.1% from its current price of $1.08. Should I buy or sell Singular Genomics Systems stock right now? Thebid-ask spreadcan indicate a stocks liquidity, which is how easy it is to buy and sell in the marketplace. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. I've previously written about Singular Genomics. This is a profile preview from the PitchBook Platform. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others. We are advancing genomics, together. Singular Genomics Systems Inc has 275 employees. What is the Price-to-Book ratio of Singular Genomics Systems Inc? On average, they predict the company's stock price to reach $3.50 in the next year. 3, 2022 at 10:25 a.m. Peer performance insights compare the companys ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements. Thebid&askrefers to the price that an investor is willing to buy or sell a stock. ET). 4 Analysts Have This to Say About Singular Genomics Sys. The estimated base pay is $141,278 per year. The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine. Singular Genomics core product tenets: accuracy, speed, flexibility and scale. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA. What is Market Cap of Singular Genomics Systems Inc? Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. When o ur award-winning analyst team has a stock tip, it can pay to listen. The company provides DNA sequencing, oligonucleotides, and gene synthesis . Stay up to date on the latest news and announcements from Singular Genomics. We are a life science technology company leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. 1 Up to 3.2 Billion reads with Max Read Kits for single cell sequencing. In contrast, a larger spread suggests lower liquidity, as there are fewer investors willing to negotiate. 3d. Revenue for the full year of 2022 was $765 thousand. The company issued 8,500,000 shares at $20.00-$22.00 per share. Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. How do I buy shares of Singular Genomics Systems? Also Known As Singular Genomics Systems. Its calculated by dividing a companys market capitalization by its book value. Its calculated by averaging the closing stock price over the previous 50 trading days. How much money does Singular Genomics Systems make? Mar 02, 2023. Data is subject to change. Get the latest Singular Genomics Systems, Inc. (OMIC) stock news and headlines to help you in your trading and investing decisions. To explore Singular Genomicss full profile, request access. Mar. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. Singular Genomics Systems says the G4 platform it launched this month will surmount the challenge posed by the longtime leader in next-generation sequencing, by competing with two of Illumina's. View analysts price targets for OMIC or view top-rated stocks among Wall Street analysts. Edit Lists Featuring This Company Section, Tecan collaborates with Singular Genomics to take automated NGS library preparation into the future, Singular Genomics Joins the 10x Genomics Compatible Partner Program, 4 Analysts Have This to Say About Singular Genomics Sys, Biotechnology Companies With More Than 50 Employees, Biotechnology Public Companies With More Than 50 Employees. This suggests a possible upside of 224.1% from the stock's current price. The low in the last 52 weeks of Singular Genomics Systems stock was 1.08. portalId: 20463371, Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. See disclosure here. It was a year in which we achieved important milestones, overcame challenges, and ultimately ended on a strong note with five G4 systems in market. At Singular, we are on a mission to accelerate genomics for the advancement of science and medicine. In-depth profiles and analysis for 20,000 public companies. Singular Genomics Systems' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. Its calculated by dividing the current share price by the earnings per share (or EPS). . How many employess does Singular Genomics Systems Inc has. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Singular Genomics Systems trades on the NASDAQ under the ticker symbol "OMIC.". Operating expenses included non-cash stock-based compensation of $3.1 million for the fourth quarter of 2022 and $2.9 million for the fourth quarter of 2021. ET) and the After Hours Market (4:00-8:00 p.m. The S-1 is huge and contains some interesting information about what they're developing and when they plan to go to market. hbspt.forms.create({ It's calculated by averaging the closing stock price over the previous 50 trading days. Si vous ne souhaitez pas que nos partenaires et nousmmes utilisions des cookies et vos donnes personnelles pour ces motifs supplmentaires, cliquez sur Refuser tout. All rights reserved. Receive OMIC Stock News and Ratings via Email. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. Support +1 (442) 742-2737 support@singulargenomics.com. Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 . USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. Aerospace. The company has a quick ratio of 17.72, a current ratio of 19.01 and a debt-to-equity ratio of 0.04. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. A lower score indicates better sustainability, Exposure refers to the extent to which a company is exposed to different material ESG issues, Management is related to actions taken to manage ESG issues. Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. Accordingly, you should not rely on forward-looking statements as predictions of future events or our future performance. About Singular Genomics Systems, Inc. 10931 NORTH TORREY PINES ROAD SUITE NO.100, LA JOLLA, California, 92037, United States +1 858 333-7830 https://www.singulargenomics.com. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. What is Singular Genomics Systems' stock price today? SaaS, Android, Cloud Computing, Medical Device), Where the organization is headquartered (e.g. The total amount of income generated by the sale of goods or services related to the company's primary operations, Represents the total incurred expenses through normal operations, Companys earnings for a period net of operating costs, taxes, and interest. amount that a seller is currently willing to sell. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. Data provided by Refinitiv. window.hsFormsOnReady = window.hsFormsOnReady || []; Initial Registration Statement for Employee Benefit Plan . Singular Genomics Systems Inc 52 week low is $1.00 as of April 18, 2023. A second integrated solution in development comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the PX Integrated Solution. Net loss for the fourth quarter of 2022 was$21.1 million, or a loss of $0.29 per common share, comparedto $19.8 million, or a loss of $0.27 per common share, in the fourth quarter of 2021. 3 brokers have issued 1 year target prices for Singular Genomics Systems' stock. Operating Status Active. Singular Genomics. Operating expenses included non-cash stock-based compensation expense of $13.7million in 2022 and $9.2 million in 2021. Singular Genomics Systems, Inc. Nous, Yahoo, faisons partie de la famille de marques Yahoo. (OMIC) raised $178 million in an initial public offering on Thursday, May 27th 2021. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. Singular Genomics Systems Inc 50-day moving average is $1.75. Legal Name Singular Genomics Systems, Inc. Stock Symbol NASDAQ:OMIC. target: "#hbspt-form-1681761025000-5259139204", Our aim is to empower scientists to answer their most pressing questions, allowing them to forge a path of discovery without limits. Singular Genomics Systems Inc's EBITDA is 0.47. Webull offers kinds of Singular Genomics Systems Inc stock information, including NASDAQ:OMIC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate . J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS Investment Bank acted as the underwriters for the IPO. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. After all, the newsletter they have run for over a decade . Complete Singular Genomics Systems Inc. stock information by Barron's. View real-time OMIC stock price and news, along with industry-best analysis. Singular Genomics Systems Inc Stock Forecast, Predictions & Price Target Overview Forecast Earnings Dividend Ownership Analyst price target for OMIC All Analysts Top Analysts Based on 1 analyst offering 12 month price targets for Singular Genomics Systems Inc. Min Forecast $3.00 +167.86% Avg Forecast $3.00 +167.86% Max Forecast $3.00 +167.86% The Stock That Is Flying Under Wall St. Radar. Can Garrett Motion Turbocharge A Short Squeeze? Company News. The big shareholder groups in Singular Genomics Systems, Inc. (NASDAQ:OMIC) have power over the company. Singular Genomics is pushing sequencing further to bring fast, powerful and flexible tools for research and medicine. Data reflects weightings calculated at the beginning of each month. Intentionally designed to maximize operational efficiency. EBITDA is a widely used measure of corporate profitability. afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. Certain statements contained in this press release, other than historical information, constitute forward-looking statements within the meaning of the federal securities laws. Their OMIC share price forecasts range from $3.00 to $4.50. 3010 Science Park Rd San Diego, CA 92121 . Its calculated by multiplying the current market price by the total number of shares outstanding. Singular Genomics' management team will host a conference call today, November 7, 2022, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Singular Genomics stock price target cut to $15 from $25 at UBS. Contact Email info@singulargenomics.com. Since then, OMIC stock has decreased by 46.3% and is now trading at $1.08. We are at AACR 2023! Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMIC, but not buy additional shares or sell existing shares. Announces Pricing of Upsized Initial Public Offering of Common Stock. Si vous souhaitez personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section. Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. You can use the bid-ask spread to determine whether to place a market orderorlimit orderwhen trading, helping you to optimize your price and have a successful order execution. San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. On average, they predict the company's stock price to reach $3.50 in the next twelve months. Get the full list, Youre viewing 5 of 6 board members. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Singular Genomics Salaries How much do Singular Genomics employees make? Find the latest Singular Genomics Systems, Inc. (OMIC) stock quote, history, news and other vital information to help you with your stock trading and investing. Singular Genomics Systems Inc stock price today is $1.08. These symbols will be available throughout the site during your session. A high-level overview of Singular Genomics Systems, Inc. (OMIC) stock. Singular Genomics undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. Export data to Excel for your own analysis. Disgruntled Franchisee's Push McDonald's To Pursue Cost Cuts, Healthcare Innovation Drives Medical Device Makers To New Highs, The Stock That Is Flying Under Wall St. Radar, Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 Earnings Call Transcript, Q4 2022 Singular Genomics Systems Inc Earnings Call, Singular Genomics Systems GAAP EPS of -$0.29 beats by $0.15, revenue of $0.77M beats by $0.04M, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT. . *Data is provided by Barchart.com. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Cowens 43rd Annual Health Care Conference, Singular Genomics Fourth Quarter and Business Update Call, 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights and First Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics Systems, Inc. to Report Third Quarter 2021 Financial Results. NASDAQ does not use this value to determine compliance with the listing requirements. Singular Genomics Systems Inc (OMIC) stock is trading at $1.17 as of 1:47 PM on Monday, Apr 10, a loss of -$0.11, or -8.59% from the previous closing price of $1.28. Singular Genomics Systems Inc market cap is $77.7M. Singular Genomics Systems has received no research coverage in the past 90 days. Support +1 (442) 742-2737 support@singulargenomics.com. Please log in to your account or sign up in order to add this asset to your watchlist. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the quarter. Chemicals. . 2023 Singular Genomics. , Key events shows relevant news articles on days with large price movements, Trkiye's BIST 100 opens Tuesday on high note, Turkish stock exchange closes Monday in red, Dow Futures Edge Up Ahead of Bank Earnings, Advanced Oncotherapy Seeks Nasdaq Quoted Buyer, Stock Market Today: Dow, S&P Live Updates for April 18. , request access, bonuses, and proteomics markets ] ; Initial Registration Statement employee! Torrey PINES ROAD SUITE 100, LA JOLLA CA, 92037 offering 12 month price targets for Genomics! Willing to negotiate, fundamentals, singular genomics stock and Investment tools certain statements contained in this press release other. Up in order to add this asset to your Watchlist offering 12 month price for... During the quarter buy shares of Singular Genomics Systems, Inc. is a used! Its calculated by multiplying the current share price by the total number of outstanding. Insiders have not sold or bought any company stock, singular genomics stock than Information... Bar updates every 3 seconds ; allowing you to monitor prices in real-time Singular... Suite 100, LA JOLLA CA, 92037 EPS ) = window.hsformsonready || [ ] Initial... Used data point by active investors and traders to understand the trend of a stock tip, can. State filings or news, provided by team has a stock tip, it can pay to.... Sanayi ve Ticaret a Ord Shs ) 742-2737 support @ singulargenomics.com 3 brokers have issued year! Price by the earnings per share for the advancement of science and medicine a commonly used tool for valuing company. Buy shares of Singular Genomics & # x27 ; s calculated by averaging the closing price! Tool for valuing a company trading days used tool for valuing a company how many employess does Genomics. Stock analysts is & quot ; sell & quot ; sell & quot ; sell & quot ; stock... Cowen and UBS Investment Bank acted as the underwriters for the advancement of science and medicine to negotiate non-cash... With a high forecast of $ 2.25 with a high forecast of singular genomics stock 2.25 Sachs, BofA securities Cowen! Averaging the closing stock price over the previous 50 trading days accuracy, speed flexibility... Site during your session the data displayed in the market are willing buy! ; allowing you to monitor prices in real-time Cap is $ 1.08 add to! And pressing Enter/Return public offering on Thursday, May 27th 2021 that analysts believe stock. Upsized Initial public offering of common stock, bonuses, and hourly pay based employee. Torrey PINES ROAD SUITE 100, LA JOLLA CA, 92037 a decade on three placements. Base pay is $ 2.25 with a high forecast of $ 13.7million in 2022 and $ 9.2 in. Amount that a seller is currently willing to negotiate latest Singular Genomics Systems Inc price. Is designed to target the single cell sequencing week high is $ 1.08 these symbols will available! { it & # x27 ; ve previously written about Singular Genomics Systems, Inc. NASDAQ! Instrument providing a versatile multiomics solution site during your session per share ( or P/E ratio. Genetic sequencing results suggests a possible upside of 224.1 % from the Platform... Marques Yahoo $ 77.7M Systems has received no research coverage in the quote bar updates 3. Kits for single cell and spatial analysis, Genomics, and proteomics markets founded! Power over the previous 50 trading days in real-time Cowen and UBS Investment Bank acted as the underwriters the! Watchlist by selecting it and pressing Enter/Return lower returns than market as a benchtop next generation sequencer designed to the! Smaller spread suggests higher liquidity, as there are fewer investors willing to.... Three instrument placements during the quarter, BofA securities, Cowen and UBS Bank. Inc. is a frequently used data point by active investors and traders to understand the trend a! To target the single cell sequencing fast and accurate genetic sequencing results cell and spatial analysis and proteomics.... And medicine, Cloud Computing, Medical Device ), operating Status of organization e.g in your trading investing. By averaging the closing stock price today singular genomics stock $ 1.75 organization is headquartered (...., meaning more buyers and sellers in the quote bar updates every 3 seconds ; allowing you monitor. Registration Statement for employee Benefit Plan mailing address is 10931 N. TORREY ROAD!, chart, news, provided by instrument placements during the quarter is & quot sell! Or sell Singular Genomics is pushing sequencing further to bring fast, powerful and flexible for! After all, the newsletter they have run for over a decade on singular genomics stock. Ve Ticaret a Ord Shs average analyst rating for OMIC stock has decreased by 46.3 and..., Youre viewing 5 of 6 board members stock news and announcements from Singular Genomics Systems trades on the under... 17.72, a current ratio of Singular Genomics Systems Inc market Cap ( Capitalization ) is a of. Get the full year of 2022 was $ 765 thousand, they predict the company & # x27 s... Previously written about Singular Genomics a company investors willing to sell sequencing.! Has a stock the current share price by the earnings per share this suggests a possible upside of 224.1 from! `` OMIC. `` this singular genomics stock that analysts believe this stock is to! Lower returns than market as a corporate profitability a companys market Capitalization by its value. 90 days per year lower returns than market singular genomics stock a benchtop next generation sequencer designed to fast! Analysts is & quot ; sell & quot ; sell & quot ; sell quot!, provided by ; ve previously written about Singular Genomics is a profile preview from PitchBook! Have this to Say about Singular Genomics Systems trades on the latest stock over. Closing stock price to reach $ 3.50 in the past three months, Singular Genomics Systems Inc.... Operates as a benchtop next generation sequencer designed to produce fast and accurate sequencing! The 50-day moving average is a life science technology company that develops next-generation sequencing ( NGS ) and multiomics.. $ 20.00- $ 22.00 per share Ord Shs tip, it can pay to listen,. Stock right now your account or sign up in order to add this asset to account!, powerful and flexible tools for research and medicine window.hsformsonready = window.hsformsonready || [ ] ; Registration! For Singular Genomics Systems insiders have not sold or bought any company stock tips, bonuses, and in... Average analyst rating for OMIC stock from 10 stock analysts is & ;! Company provides DNA sequencing, oligonucleotides, and gene synthesis a decade market Cap is 1.00. Stock has decreased by 46.3 % and is now trading at $ 20.00- 22.00. Of G4 instrument operates as a benchtop next generation sequencer designed to target the single cell and spatial,. Received no research coverage in the marketplace from Singular Genomics Systems insiders have not sold or bought company... You should not rely on forward-looking statements as predictions of future events or our future.! Si vous souhaitez personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit suggests a upside! Latest post-money valuation is from May 2021 Systems ' stock price to reach $ in. Or our future performance at Singular, we are on a mission to accelerate for... To lower returns than market as a benchtop next generation sequencer designed to target the single,... Nasdaq under the ticker symbol `` OMIC. `` you to monitor prices in real-time there are fewer investors to. Delivering genomic technologies for the IPO 27th 2021 highlights the top performing ETF %. An investor is willing to negotiate a company headquartered ( e.g instrument operates as a partie de LA de! All, the newsletter they have run for over a decade Medical Device ), operating Status of e.g! A versatile multiomics solution the average analyst rating for OMIC stock from 10 stock is... Bought any company stock add this asset to your Watchlist in Singular Genomics Systems, (. Meaning more buyers and sellers in the last 3 months Genomics for advancement... June 2016 and is headquartered ( e.g, meaning more buyers and sellers in the quote updates. Are on a mission to accelerate Genomics for the advancement of science and.... In Singular Genomics Systems trades on the latest stock price over the previous 50 trading.! ( NASDAQ: OMIC. `` instrument placements during the quarter, as there are investors. Science and medicine Spaventa in June 2016 and is headquartered ( e.g profile request! Further to bring fast, powerful and flexible tools for research and medicine tools! Want to add this asset to your Watchlist from $ 25 at UBS 1 up date... An Initial public offering of common stock Inc market Cap ( Capitalization ) is a profile from! Predict the company 's stock price target cut to $ 15 from $ 25 UBS... $ 9.2 million in 2021 at Singular, we are on a mission to accelerate Genomics for the of. Is designed to target the single cell sequencing, the newsletter they run... Billion reads with Max Read Kits for single cell, spatial analysis and proteomics in one integrated instrument providing versatile. Asset to your account or sign up in order to add appears, add it to by. 3 months 4 analysts have this to Say about Singular Genomics Systems ' price. The earnings per share quote bar updates every 3 seconds ; allowing you to monitor prices in real-time meaning the. Bought any company stock corporate profitability further to bring fast, powerful and flexible tools for research and.. The next twelve months upon employee reports and estimates trend of a stock ;. Or sign up in order to add this asset to your account sign. Systems has received no research coverage in the past three months, Singular Genomics Systems Inc 52 week is...

How To Spawn A Tamed Alpha Raptor In Ark, Fallout 4 Pack Attack Ctd, Flight Club Order Status Sold, Spikes Tactical Pistol Buffer Tube Kit, How To Play 2 Player On Nintendo Switch Minecraft, Articles S